Company Filing History:
Years Active: 2018
Title: Roberta Marino: Innovator in Multiple Myeloma Imaging and Therapy
Introduction
Roberta Marino is a distinguished inventor based in Cordova, TN (US). She has made significant contributions to the field of medical imaging and therapy, particularly in the treatment of multiple myeloma. Her innovative work has led to the development of a unique patent that addresses critical needs in cancer detection and treatment.
Latest Patents
Roberta Marino holds a patent for "Alkylphosphocholine analogs for multiple myeloma imaging and therapy." This patent discloses that certain alkylphosphocholine analogs are preferentially taken up by multiple myeloma tumor cells. The compounds described in the patent have the formula where n is an integer from 12 to 24, and R can be various chemical groups that enhance the compound's effectiveness. These compounds can be utilized both for therapeutic treatment and for detecting multiple myeloma. In therapeutic applications, R includes a radionuclide that delivers targeted radiation to tumor cells. In imaging applications, R includes a detection moiety, such as a fluorophore or a radiolabel. Roberta Marino's innovative approach has the potential to significantly improve outcomes for patients suffering from this challenging disease.
Career Highlights
Roberta Marino's career is marked by her dedication to advancing medical science through her inventions. Her work at the Wisconsin Alumni Research Foundation has allowed her to collaborate with other talented researchers and contribute to groundbreaking developments in cancer therapy. With her patent, she has established herself as a key figure in the field of medical innovation.
Collaborations
Roberta has worked alongside notable colleagues, including Jamey Paul Weichert and Chorom Pak. Their collaborative efforts have further enhanced the research and development of effective treatments for multiple myeloma.
Conclusion
Roberta Marino's contributions to the field of medical imaging and therapy exemplify the impact of innovative thinking in addressing complex health challenges. Her patent for alkylphosphocholine analogs represents a significant advancement in the fight against multiple myeloma.